Andrew C. Huntsman
Pharmacology, Toxicology and Pharmaceutics · The Ohio State University
Publications
16
Citations
178
Est. group size
~1
Recurring co-author estimate
Active years
12
Publishing since 2013
Andrew C. Huntsman's research focuses on natural products derived from fungi, particularly a class of compounds called verticillins, which show potential as anti-cancer (chemotherapeutic) agents. Work includes both studying these compounds as they occur in nature and chemically modifying them to create new derivatives with potentially improved properties. This research sits within pharmacology and medicinal chemistry, exploring how natural fungal molecules might be developed into therapeutic drugs.
Publication output has been low and irregular over the past decade, with a notable spike in 2023 followed by a return to a slower pace, averaging about 1-2 papers per year in the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Verticillins: fungal epipolythiodioxopiperazine alkaloids with chemotherapeutic potential
Natural Product Reports · 2024
- Semisynthetic Derivatives of the Verticillin Class of Natural Products through Acylation of the C11 Hydroxy Group
ACS Medicinal Chemistry Letters · 2021
- Cell Death and Disease×1
- Bioorganic & Medicinal Chemistry×1
- European Journal of Medicinal Chemistry×1
- Molecular Cancer Therapeutics×1
- ACS Medicinal Chemistry Letters×1
- Hong Li
Medicine · The Ohio State University
- Abtar Mishra
Medicine · Purdue University West Lafayette
- Abdalla Elbialy
Medicine · The Ohio State University
- Bhawana Bissa
Medicine · The Ohio State University
- Hsuan-Yeh Pan
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile